125 related articles for article (PubMed ID: 34536296)
1. Low-dose aspirin use and mortality risk in patients with head and neck cancer: A nationwide cohort study of 10 770 patients.
de la Cour CD; von Buchwald C; Dehlendorff C; Garset-Zamani M; Grønhøj C; Carlander AF; Friis S; Kjaer SK
Int J Cancer; 2022 Mar; 150(6):969-975. PubMed ID: 34536296
[TBL] [Abstract][Full Text] [Related]
2. Non-aspirin NSAIDs and head and neck cancer mortality in a Danish nationwide cohort study.
de la Cour CD; Dehlendorff C; von Buchwald C; Garset-Zamani M; Grønhøj C; Carlander AF; Friis S; Kjaer SK
Cancer Epidemiol; 2022 Apr; 77():102121. PubMed ID: 35183905
[TBL] [Abstract][Full Text] [Related]
3. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
[TBL] [Abstract][Full Text] [Related]
4. Low-dose aspirin use and endometrial cancer mortality-a Danish nationwide cohort study.
Sperling CD; Verdoodt F; Aalborg GL; Dehlendorff C; Friis S; Kjaer SK
Int J Epidemiol; 2020 Feb; 49(1):330-337. PubMed ID: 31845990
[TBL] [Abstract][Full Text] [Related]
5. Aspirin use and head and neck cancer survival: an observational study of 11,623 person-years follow-up.
Kim SA; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Int J Clin Oncol; 2018 Feb; 23(1):52-58. PubMed ID: 28725937
[TBL] [Abstract][Full Text] [Related]
6. Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study.
Bens A; Friis S; Dehlendorff C; Jensen MB; Ejlertsen B; Kroman N; Cronin-Fenton D; Mellemkjær L
Prev Med; 2018 Nov; 116():186-193. PubMed ID: 30261243
[TBL] [Abstract][Full Text] [Related]
7. Trends in all-cause five-year mortality after head and neck cancers diagnosed over a period of 33 years. Focus on estimated degree of association with human papillomavirus.
Svahn MF; Munk C; Nielsen TS; von Buchwald C; Frederiksen K; Kjaer SK
Acta Oncol; 2016; 55(9-10):1084-1090. PubMed ID: 27550781
[TBL] [Abstract][Full Text] [Related]
8. Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Dalton SO; Nørgaard M; Pottegård A; Hallas J; Sørensen HT; Friis S
Ann Intern Med; 2019 Apr; 170(7):443-452. PubMed ID: 30831581
[TBL] [Abstract][Full Text] [Related]
9. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830
[TBL] [Abstract][Full Text] [Related]
10. Low-dose aspirin use and survival in breast cancer patients: A nationwide cohort study.
Mc Menamin ÚC; Cardwell CR; Hughes CM; Murray LJ
Cancer Epidemiol; 2017 Apr; 47():20-27. PubMed ID: 28088656
[TBL] [Abstract][Full Text] [Related]
11. Aspirin use and ovarian cancer mortality in a Danish nationwide cohort study.
Verdoodt F; Kjaer SK; Dehlendorff C; Friis S
Br J Cancer; 2018 Feb; 118(4):611-615. PubMed ID: 29315293
[TBL] [Abstract][Full Text] [Related]
12. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
13. Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer.
Macfarlane TV; Murchie P; Watson MC
Cancer Epidemiol; 2015 Dec; 39(6):1015-22. PubMed ID: 26590503
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C Virus RNA Transcript Associates with Prognosis in Non-human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma.
Tang B; Zhu G; Chen C; Zheng S; Pu Y; Xu Y; Huang H; Wang G; Huang D; Liu Y; Zhang X
Laryngoscope; 2021 Aug; 131(8):1774-1781. PubMed ID: 33592124
[TBL] [Abstract][Full Text] [Related]
15. Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy.
Adjei Boakye E; Buchanan P; Hinyard L; Stamatakis K; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
Laryngoscope; 2019 Aug; 129(8):1828-1835. PubMed ID: 30582167
[TBL] [Abstract][Full Text] [Related]
16. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
17. Academic Affiliation and Surgical Volume Predict Survival in Head and Neck Cancer Patients Receiving Surgery.
Farquhar DR; Masood MM; Lenze NR; Sheth S; Patel SN; Lumley C; Zanation AM; Weissler MC; Olshan AF; Hackman TG
Laryngoscope; 2021 Feb; 131(2):E479-E488. PubMed ID: 32449832
[TBL] [Abstract][Full Text] [Related]
18. Non-aspirin NSAID use and ovarian cancer mortality.
Verdoodt F; Dehlendorff C; Friis S; Kjaer SK
Gynecol Oncol; 2018 Aug; 150(2):331-337. PubMed ID: 29960709
[TBL] [Abstract][Full Text] [Related]
19. Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.
Spence AD; Busby J; Johnston BT; Baron JA; Hughes CM; Coleman HG; Cardwell CR
Gastroenterology; 2018 Mar; 154(4):849-860.e1. PubMed ID: 29122547
[TBL] [Abstract][Full Text] [Related]
20. Aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer: A population-based analysis.
Lin YS; Yeh CC; Huang SF; Chou YS; Kuo LT; Sung FC; Muo CH; Su CT; Su FH
PLoS One; 2018; 13(8):e0199014. PubMed ID: 30133455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
